Brokers Issue Forecasts for NAMS FY2026 Earnings
NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for NewAmsterdam Pharma in a report released on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse anticipates that the company will earn ($2.25) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating […]
NewAmsterdam Pharma (NASDAQ:NAMS – Free Report) – Investment analysts at Cantor Fitzgerald issued their FY2026 earnings per share (EPS) estimates for NewAmsterdam Pharma in a report released on Monday, June 9th. Cantor Fitzgerald analyst S. Seedhouse anticipates that the company will earn ($2.25) per share for the year. Cantor Fitzgerald currently has a “Overweight” rating […]
